BNF:

8.3.4.3

Status:

Amber

Decision Date:

None

Comments

See shared care guideline for somatostatin analogues

Amber Drug Classifications

• 1: Requiring specialist assessment to enable patient selection and initiation of treatment
• 5: Requires specific long term monitoring for toxicity needing on-going specialist support

search again